Enliven Therapeutics, Inc.
ELVN
$36.40
$0.290.80%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 452.40M | 462.62M | 477.57M | 490.50M | 289.56M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 10.74M | 12.26M | 5.12M | 5.12M | 4.76M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 463.14M | 474.88M | 482.68M | 495.62M | 294.32M |
|
|
|||||
| Total Current Assets | 463.14M | 474.88M | 482.68M | 495.62M | 294.32M |
| Net Property, Plant & Equipment | 310.00K | 417.00K | 874.00K | 1.03M | 1.06M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.41M | 873.00K | 7.32M | 7.24M | 7.20M |
| Total Assets | 464.85M | 476.17M | 490.88M | 503.89M | 302.57M |
|
|
|||||
| Total Accounts Payable | 1.64M | 2.16M | 1.43M | 2.35M | 1.56M |
| Total Accrued Expenses | 9.44M | 13.66M | 12.75M | 12.42M | 11.90M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 302.00K | 399.00K | 387.00K | 376.00K | 365.00K |
| Total Finance Division Other Current Liabilities | 107.00K | 351.00K | 86.00K | 63.00K | 146.00K |
| Total Other Current Liabilities | 107.00K | 351.00K | 86.00K | 63.00K | 146.00K |
| Total Current Liabilities | 11.49M | 16.57M | 14.65M | 15.21M | 13.97M |
|
|
|||||
| Total Current Liabilities | 11.49M | 16.57M | 14.65M | 15.21M | 13.97M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | 103.00K | 204.00K | 302.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 11.49M | 16.57M | 14.75M | 15.42M | 14.27M |
|
|
|||||
| Common Stock & APIC | 824.54M | 806.43M | 793.40M | 786.00M | 560.33M |
| Retained Earnings | -370.79M | -347.17M | -317.50M | -297.35M | -272.02M |
| Treasury Stock & Other | -382.00K | 334.00K | 221.00K | -177.00K | -16.00K |
| Total Common Equity | 453.37M | 459.60M | 476.12M | 488.47M | 288.30M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 453.37M | 459.60M | 476.12M | 488.47M | 288.30M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 453.37M | 459.60M | 476.12M | 488.47M | 288.30M |
|
|
|||||